Salient Bio
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
Salient Bio firmographics
Firmographics- Name
- Salient Bio
- Legal name
- Salient Labs Limited
- Website
- https://salient.bio
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Salient Bio industry classification
Industry- Product category
- Microbiome Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
- akta.pro secondary industries
- Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Salient Bio is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Salient Bio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Diagnostic Testing Services: Revenue from proprietary MHRA-registered diagnostic tests such as IBD SIGNAL, and broad pathology testing including stool, blood, and STI testing panels. Tests are delivered through a secure digital platform with portal and API access for clinical and commercial environments.
- Wellness Testing for Professional Use: Oral, vaginal, and gut microbiome wellness tests designed for clinical and commercial healthcare services. Features shotgun metagenomic sequencing, species-level organism reporting, and structured reporting delivered via portal or API.
- White-Label Pathology Services: White-label, grey-label, and home-testing kit services for partners who want to offer diagnostic services under their own branding. Clients include healthcare providers and commercial services seeking to integrate pathology testing without building internal laboratory infrastructure.
- Specialist Microbiome Analysis: Accredited laboratory testing supporting specialist microbiome analysis across human and non-human samples within a regulated framework. Delivered as a service to research institutions and commercial partners requiring advanced microbiome analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B partnership pricing for diagnostic and wellness testing services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Salient Bio product offering
Product offeringCore offering
Salient Bio operates a UKAS-accredited, ISO 17025-compliant diagnostic laboratory offering microbiome-based testing services built on shotgun metagenomic sequencing and proprietary machine learning. Its product portfolio includes the MHRA-registered IBD SIGNAL diagnostic for inflammatory bowel disease, plus oral, vaginal, and gut microbiome wellness tests delivered to healthcare providers, fertility clinics, dental practices, and other clinical partners via portal and API. The company also provides white-label, grey-label, and home-testing-kit pathology services for partners wanting to distribute testing under their own brand.
Product overview
Salient Bio is a London-based diagnostics company offering a unified platform centered on microbiome intelligence. The core offering consists of the SIGNAL Discovery Platform, which powers proprietary diagnostic development using machine learning and metagenomics. The first regulated deployment is IBD SIGNAL, an MHRA-registered diagnostic test for inflammatory bowel disease. Complementing this are wellness tests for professional use covering oral, vaginal, and gut microbiome analysis. All offerings share a unified laboratory and data infrastructure—UKAS-accredited, ISO 17025-compliant—supporting sample processing, sequencing, classification, and structured reporting through a portal and API delivery model.
Differentiator
Problem solved
Functional benefit
Products and services
- IBD SIGNAL
Quantifiable outcome
- IBD SIGNAL achieves 96% sensitivity, 98% specificity, and 99.4% AUC-ROC against established diagnostic comparators
- +1 more outcomes
Companies that use Salient Bio
Customer profileSegments5 records
Ideal customer profiles5 records
Salient Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Salient Bio partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Salient Bio competitors and assessment
Company assessmentDirect peers
- DayTwo: Microbiome-based personalized diagnostics for metabolic health using metagenomic sequencing and ML, with similar B2B/B2B2C distribution through health providers and employers.
- Viome: Direct-to-consumer and B2B gut, oral and saliva microbiome testing using RNA/DNA sequencing with ML-driven health recommendations; competes in the same clinical-grade wellness diagnostics category.
- CosmosID: Microbiome identification and analytics services for clinical, research and industrial customers using metagenomic sequencing and curated reference databases, comparable to Salient's SIGNAL/GutTrace stack.
- Sun Genomics (Thryve): Personalized gut microbiome testing with strain-level reporting and supplements, overlapping with Salient's B2C-leaning microbiome wellness offering.
- Atlas Biomed: UK-based gut microbiome and genetic testing company offering consumer-facing and partner-distributed health reports based on DNA sequencing, closely aligned with Salient's wellness test line.
Broad incumbents
- Sonic Healthcare: Global clinical pathology and diagnostic laboratory network with established hospital and physician relationships; relevant incumbent against which Salient's specialty microbiome offering must differentiate.
- Synlab: One of Europe's largest medical diagnostic services providers, offering broad clinical and specialty testing through hospital and physician channels, operating extensively across the same UK/European geographies.
- Eurofins Scientific: Global testing services group with significant clinical diagnostics and microbiome/genomic service lines; competes with Salient for high-throughput laboratory customers and could bundle microbiome into broader panels.
Regional players
- Yourgene Health: UK-based molecular diagnostics developer with regulated reproductive health and oncology products; comparable as a UK MedTech diagnostics peer at similar stage and regulatory positioning.
- Congenica: UK clinical genomics platform with regulated IVD software for rare disease and oncology; comparable as a Cambridge-based UK diagnostics company combining accredited lab infrastructure with proprietary analytical software.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Salient Bio social profiles
Digital presenceSalient Bio compliance and trust
Trust signalCompliance2 records
Salient Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Salient Bio leadership team
Management profileNumber of profiles
Profiles4 records
Salient Bio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Salient Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Salient Bio
What does Salient Bio do?
Salient Bio operates a UKAS-accredited, ISO 17025-compliant diagnostic laboratory offering microbiome-based testing services built on shotgun metagenomic sequencing and proprietary machine learning. Its product portfolio includes the MHRA-registered IBD SIGNAL diagnostic for inflammatory bowel disease, plus oral, vaginal, and gut microbiome wellness tests delivered to healthcare providers, fertility clinics, dental practices, and other clinical partners via portal and API. The company also provides white-label, grey-label, and home-testing-kit pathology services for partners wanting to distribute testing under their own brand.
Is Salient Bio a public or private company?
Salient Bio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Salient Bio founded?
Salient Bio was founded in 2020. It employs 11 to 50 people.
Where is Salient Bio based?
Salient Bio is headquartered in London, United Kingdom, in the Europe region.
How does Salient Bio make money?
Four revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are wellness Testing for Professional Use, white-Label Pathology Services and specialist Microbiome Analysis.
Who are Salient Bio's main competitors?
Direct peers on record are DayTwo, Viome, CosmosID, Sun Genomics (Thryve) and Atlas Biomed. Broad incumbents are Sonic Healthcare, Synlab and Eurofins Scientific. Regional players are Yourgene Health and Congenica.
Does Salient Bio have an API?
Yes. Integration-ready Portal + API for existing systems. Salient Bio offers API delivery for clinical and commercial environments, enabling integration into existing care pathways and services.
What industry is Salient Bio in?
Salient Bio's product category is Microbiome Diagnostics. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAALAN, Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays. Its NAICS code is 6215 and its SIC code is 8071.